Acquisition of the aggressive tumor characteristics in clear cell renal cancer (ccRCC) cells is attributed to the CD98hc-integrin binding, whereas silencing of CD98hc decreases tumor cell spreading, migration and proliferation, and tumor growth in vivo (14). Here, SLC3A2 is linked to nonpapillary renal cell carcinoma.